Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
This report contains market size and forecasts of Risedronate in global, including the following market information:
Global Risedronate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Risedronate Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Risedronate companies in 2021 (%)
The global Risedronate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5 mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Risedronate include Merck, Amgen, Teva, Mylan, Apotex, Sanofi, Abbott, Novartis and Tecoland and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Risedronate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Risedronate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Risedronate Market Segment Percentages, by Type, 2021 (%)
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Global Risedronate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Risedronate Market Segment Percentages, by Application, 2021 (%)
Postmenopausal Osteoporosis
Men with Osteoporosis
Global Risedronate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Risedronate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Risedronate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Risedronate revenues share in global market, 2021 (%)
Key companies Risedronate sales in global market, 2017-2022 (Estimated), (MT)
Key companies Risedronate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals